HAEMONETICS CORP — Director's Dealing 2012

Jun 25, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2012-06-21

Reporting Person: FORISH JOSEPH J (VP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-21	Common Stock	M	12000.0	$48.195	Acquired	20497.0	Direct
2012-06-21	Common Stock	S	12000.0	$71.138	Disposed	8497.0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-21	Non-Qualified Stock Option (right to buy)	$48.195	M	12000.0	Disposed	2012-12-19	Common Stock (12000.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$51.07	2014-10-24	Common Stock (11799.0)	11799.0	Direct
Non-Qualified Stock Option (right to buy)	$52.76	2013-05-05	Common Stock (10373.0)	10373.0	Direct
Non-Qualified Stock Option (right to buy)	$52.94	2016-10-27	Common Stock (14690.0)	14690.0	Direct
Non-Qualified Stock Option (right to buy)	$54.55	2015-10-22	Common Stock (11911.0)	11911.0	Direct
Non-Qualified Stock Option (right to buy)	$54.99	2017-10-27	Common Stock (15388.0)	15388.0	Direct
Non-Qualified Stock Option (right to buy)	$61.34	2018-10-25	Common Stock (15370.0)	15370.0	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan.

F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.

F3: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.